A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Clinical trial NCT04951622 · RECRUITING
Trial details
- NCT number
- NCT04951622
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-15
- Primary completion
- 2023-11-17
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.